Mackenzie Financial Corp Abb Vie Inc. Transaction History

Mackenzie Financial Corp

$66.8 Billion
Q3 2024

A detailed history of Mackenzie Financial Corp transactions in Abb Vie Inc. stock. As of the latest transaction made, Mackenzie Financial Corp holds 2,328,253 shares of ABBV stock, worth $415 Million. This represents 0.69% of its overall portfolio holdings.

Number of Shares

2,328,253

Previous 2,307,363 0.91%

Holding current value

$415 Million

Previous $396 Million 16.18%

% of portfolio

0.69%

Previous 0.63%

30 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 13, 2024	BUY	$163.84 - $199.33 $3.42 Million - $4.16 Million	20,890 Added 0.91%	2,328,253 $460 Million
Q2 2024 Aug 14, 2024	BUY	$154.79 - $180.76 $35.3 Million - $41.2 Million	227,957 Added 10.96%	2,307,363 $396 Million
Q1 2024 May 10, 2024	BUY	$159.82 - $182.1 $41.6 Million - $47.4 Million	260,556 Added 14.33%	2,079,406 $379 Million
Q4 2023 Jan 30, 2024	BUY	$137.6 - $154.97 $27 Million - $30.4 Million	195,901 Added 12.07%	1,818,850 $282 Million
Q3 2023 Oct 25, 2023	SELL	$133.59 - $154.65 $1.74 Million - $2.01 Million	-13,029 Reduced 0.8%	1,622,949 $242 Million
Q2 2023 Aug 03, 2023	SELL	$132.51 - $164.9 $12.6 Million - $15.7 Million	-95,033 Reduced 5.49%	1,635,978 $220 Million
Q1 2023 Apr 24, 2023	SELL	$144.61 - $166.54 $16.8 Million - $19.3 Million	-116,130 Reduced 6.29%	1,731,011 $276 Million
Q4 2022 Feb 14, 2023	SELL	$138.31 - $165.87 $10.4 Million - $12.5 Million	-75,158 Reduced 3.91%	1,847,141 $299 Million
Q3 2022 Oct 07, 2022	SELL	$134.21 - $153.93 $5.09 Million - $5.83 Million	-37,904 Reduced 1.93%	1,922,299 $258 Million
Q2 2022 Aug 10, 2022	BUY	$137.62 - $174.96 $4.23 Million - $5.38 Million	30,757 Added 1.59%	1,960,203 $300 Million
Q1 2022 May 13, 2022	BUY	$131.98 - $163.75 $1.31 Million - $1.62 Million	9,892 Added 0.52%	1,929,446 $313 Million
Q4 2021 Feb 14, 2022	SELL	$107.43 - $135.93 $58.9 Million - $74.5 Million	-547,873 Reduced 22.2%	1,919,554 $260 Million
Q3 2021 Nov 08, 2021	SELL	$106.4 - $120.78 $12.9 Million - $14.6 Million	-121,276 Reduced 4.68%	2,467,427 $266 Million
Q2 2021 Aug 11, 2021	BUY	$105.21 - $117.21 $11.6 Million - $13 Million	110,542 Added 4.46%	2,588,703 $292 Million
Q1 2021 May 14, 2021	BUY	$102.3 - $112.62 $22.2 Million - $24.4 Million	216,889 Added 9.59%	2,478,161 $268 Million
Q4 2020 Feb 10, 2021	BUY	$80.49 - $108.67 $100 Million - $135 Million	1,246,737 Added 122.89%	2,261,272 $242 Million
Q3 2020 Nov 13, 2020	BUY	$85.91 - $100.83 $62.7 Million - $73.6 Million	729,594 Added 256.05%	1,014,535 $88.9 Million
Q2 2020 Aug 13, 2020	BUY	$73.37 - $98.18 $346,012 - $463,016	4,716 Added 1.68%	284,941 $28 Million
Q1 2020 May 14, 2020	SELL	$64.5 - $97.79 $28.7 Million - $43.5 Million	-444,899 Reduced 61.35%	280,225 $21.4 Million
Q4 2019 Feb 13, 2020	SELL	$72.13 - $90.25 $14 Million - $17.5 Million	-193,659 Reduced 21.08%	725,124 $64.2 Million
Q3 2019 Nov 14, 2019	SELL	$62.98 - $75.72 $32.9 Million - $39.6 Million	-522,594 Reduced 36.26%	918,783 $69.6 Million
Q2 2019 Aug 14, 2019	BUY	$65.7 - $83.98 $86.3 Million - $110 Million	1,313,089 Added 1023.55%	1,441,377 $105 Million
Q1 2019 May 15, 2019	SELL	$77.14 - $90.79 $9.3 Million - $11 Million	-120,623 Reduced 48.46%	128,288 $10.3 Million
Q4 2018 Feb 06, 2019	BUY	$77.85 - $96.01 $11.3 Million - $13.9 Million	144,880 Added 139.27%	248,911 $22.9 Million
Q3 2018 Nov 15, 2018	SELL	$88.91 - $98.84 $307,184 - $341,492	-3,455 Reduced 3.21%	104,031 $9.84 Million
Q2 2018 Aug 13, 2018	SELL	$89.78 - $106.23 $41.7 Million - $49.3 Million	-464,032 Reduced 81.19%	107,486 $9.96 Million
Q1 2018 May 14, 2018	SELL	$92.01 - $123.21 $17.4 Million - $23.4 Million	-189,554 Reduced 24.91%	571,518 $54.1 Million
Q4 2017 Feb 13, 2018	BUY	$89.56 - $98.21 $36.2 Million - $39.7 Million	403,868 Added 113.06%	761,072 $73.6 Million
Q3 2017 Nov 13, 2017	SELL	$69.85 - $89.22 $9.34 Million - $11.9 Million	-133,744 Reduced 27.24%	357,204 $31.7 Million
Q2 2017 Aug 14, 2017	BUY	N/A	490,948	490,948 $35.6 Million

Others Institutions Holding ABBV

# of Institutions

3,853

Shares Held

1.25B

Call Options Held

16.8M

Put Options Held

12.2M

View Full List

About AbbVie Inc.

Ticker ABBV
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 1,768,099,968
Market Cap $315B
Description
AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheuma...

More about ABBV

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Mackenzie Financial Corp, based on Form 13F filings with the SEC.

News

Stay updated on Mackenzie Financial Corp with notifications on news.

Account

Mackenzie Financial Corp Abb Vie Inc. Transaction History